Literature DB >> 11463585

Safeguarding patients in clinical trials with high mortality rates.

B D Freeman1, R L Danner, S M Banks, C Natanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11463585     DOI： 10.1164/ajrccm.164.2.2011028

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  21 in total

1.  European Society of Intensive Care Medicine statement. Clinical research in intensive care unit.

Authors:  F Lemaire
Journal:  Intensive Care Med       Date:  2002-09       Impact factor: 17.440

2.  Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.

Authors:  Roland A Matsouaka; Rebecca A Betensky
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

3.  A waiver of consent for intensive care research?

Authors:  François Lemaire
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

4.  To consent or not to consent, that is (not) the (sole) question. "And there is nothing new under the sun". Kohelet (also known as Ecclesiastes), 1:9. Bible.

Authors:  Didier Dreyfuss
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

5.  Suspension of the NIH ARDS Network fluids and catheters treatment trial.

Authors:  François Lemaire
Journal:  Intensive Care Med       Date:  2003-07-15       Impact factor: 17.440

6.  Considerations in the construction of an instrument to assess attitudes regarding critical illness gene variation research.

Authors:  Bradley D Freeman; Carie R Kennedy; Dragana Bolcic-Jankovic; Alexander Eastman; Ellen Iverson; Erica Shehane; Aaron Celious; Jennifer Barillas; Brian Clarridge
Journal:  J Empir Res Hum Res Ethics       Date:  2012-02       Impact factor: 1.742

7.  Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine?

Authors:  Jesús Villar; Lina Pérez-Méndez; Armando Aguirre-Jaime; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2004-11-23       Impact factor: 17.440

Review 8.  The importance of usual care control groups for safety monitoring and validity during critical care research.

Authors:  Peter C Minneci; Peter Q Eichacker; Robert L Danner; Steven M Banks; Charles Natanson; Katherine J Deans
Journal:  Intensive Care Med       Date:  2008-01-23       Impact factor: 17.440

9.  Mechanisms of sepsis and insights from clinical trials.

Authors:  Nitin Seam; Anthony F Suffredini
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  Surrogate receptivity to participation in critical illness genetic research: aligning research oversight and stakeholder concerns.

Authors:  Bradley D Freeman; Kevin Butler; Dragana Bolcic-Jankovic; Brian R Clarridge; Carie R Kennedy; Jessica LeBlanc; Sara Chandros Hull
Journal:  Chest       Date:  2015-04       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.